Form 8-K - Current report:
SEC Accession No. 0001493152-24-024812
Filing Date
2024-06-24
Accepted
2024-06-21 17:38:04
Documents
15
Period of Report
2024-06-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52454
2 ex10-1.htm EX-10.1 58196
  Complete submission text file 0001493152-24-024812.txt   300992

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE telo-20240618.xsd EX-101.SCH 3030
4 XBRL LABEL FILE telo-20240618_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE telo-20240618_pre.xml EX-101.PRE 22369
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3796
Mailing Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606
Business Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606 (813) 864-2562
Telomir Pharmaceuticals, Inc. (Filer) CIK: 0001971532 (see all company filings)

EIN.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41952 | Film No.: 241061519
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)